Abstract. Microsomal UDP-glucuronosyltransferase activity toward the bile acids (chenodeoxycholic, deoxycholic, ursodeoxycholic, lithocholic, and glycolithocholic) has been detected in human specimens of liver, kidney, and intestinal mucosa. The characteristics of hepatic and extrahepatic UDP-glucuronosyltransferase activities toward these bile acids were compared with respect to kinetic parameters and other catalytic properties. Whereas no organspecific differences in the affinities of individual bile acids to hepatic and extrahepatic UDP-glucuronosyltransferases were observed, the individual bile acids showed reaction rates in liver that were about twice the rates estimated in kidney and about twice to three times the rates observed in duodenal mucosa. In intestinal mucosa the rate of chenodeoxycholic acid glucuronidation exhibited a progressive decrease from duodenum to colon, where it was 30%o of the duodenal level.
Introduction
Bile acid glucuronides have been shown to be present not only in urine of patients with hepatobiliary disease (1-3), but also in urine of healthy subjects amounting to 12-36% of the total bile acid excretion in urine (4) . Therefore, in addition to sulphate esterification (5) , conjugation of bile acids with glucuronic acid may serve as a protective mechanism against accumulation of potentially toxic bile acids (6) (7) (8) (9) . However, little is known about the UDP-glucuronosyltransferase(s) involved in the glucuronidation of bile acids in man. Only some properties of the enzyme(s) from human liver have been described in previous reports (10, 11) . Enzyme activity in liver disease has not been studied. Several extrahepatic tissues such as adrenal glands ( 12) , intestine (12) (13) (14) , or kidney (12, 13, 15) of various species or human cultured lymphocytes (16) have been shown to be capable of carrying out the glucuronidation of various foreign and endogenous compounds. However, whether or not glucuronidation of bile acids also occurs in extrahepatic tissues of man is not known.
The present paper shows that in addition to the liver (10, 1 1), extrahepatic tissues such as the kidney and small intestinal mucosa are capable of glucuronidation of bile acids in man. Properties of hepatic and extrahepatic UDP-glucuronosyltransferase(s) that catalyze the glucuronidation ofbile acids are compared. Furthermore, results on hepatic bile acid conjugating activity, which were estimated from a large group of patients with a variety of liver diseases, are described.
Methods
Human tissue specimens. Liver tissue was obtained either at laparotomy or laparoscopy or after percutaneous needle biopsy of the liver with a Menghini needle. On the basis of histological findings of liver biopsy specimens and clinical assessment, the patients were classified into those with liver cirrhosis, liver fibrosis, granulomatous hepatitis, fatty liver hepatitis, fatty liver, and normal liver. Patients that comprised the group with normal liver histology were either undergoing laparotomy or laparoscopy for staging of Hodgkin's disease or were investigated for possible liver disease. Intestinal biopsy specimens were obtained from surgical patients who had undergone either Billroth II gastrectomy due to gastric ulcer (four cases) or gastric carcinoma (five cases), intestinal resection due to Crohn's disease (nine cases) or resection ofthe ileum after traumatic damage of the small intestine due to a traffic accident (one case), or adenocarcinoma of the colon (five cases). Intestinal samples which exhibited macroscopic abnormality were excluded. Kidney samples were obtained from five males who were nephrectomized for renal cancer.
Only apparently normal tissue was used. Adrenal tissue was obtained either from a 40-yr-old female operated on for adrenal hyperplasia or from a 20-yr-old male with fatal brain injury of alcoholic origin in connection with removal of kidneys for transplantation. Because of the known enzyme-inducing properties of barbiturates and of other drugs (17) , patients in whom there was a history of recent drug ingestion have been excluded. Sufficient material of all human specimens was ensured for histologic examination. Gut segments were rinsed in ice-cold saline solution immediately after the resection and were stepwise frozen first at -20°C for 24 For the assay ofbile acid conjugating activity from renal or small intestinal microsomes, the assay mixtures additionally contained 5 mM cytidine 5'-monophosphate, which was added to inhibit nucleotide pyrophosphatase activity (23) in these tissues. Bile acid glucuronidation was not affected by the presence of 5 mM cytidine 5'-monophosphate. Details ofthe assays and identification of bile acid glucuronides using thin-layer chromatography with n-butanol/acetic acid/water (50:5:10, v/v) as solvent system before and after incubation with jB-glucuronidase in the presence and absence of the ,8-glucuronidase inhibitor saccharolactone are described in another report (22) . Areas of radioactivity were located by using a type LB 2723 scanner (Laboratorium Berthold, Wildbad, Federal Republic of Germany). Spots of nonlabeled bile acids were visualized by spraying the plates with a solution of 1.5 g molybdatophosphoric acid in 10 ml acetone and heating the plates at 100°C for 2 min.
Serum bilirubin was estimated by the method of Michaelsson et al. (24) . The upper limit of normal for the total serum bilirubin with this method was 0.8 mg/l00 ml (25). DNA was determined according to Burton (26) only the monoglucuronide of deoxycholic acid was formed. Since, furthermore, for the dihydroxylated bile acids, only one reaction product was identified in thin-layer chromatography after incubation of the radioactively labeled bile acids with UDPglucuronic acid and microsomes of human liver, kidney, or duodenal mucosa, and since all of these reaction products exhibited similar Rf-values (22) that reflected similar polarity of these molecules, these results suggest that only monoglucuronides are formed from the dihydroxylated bile acids that were studied. This is in agreement with studies of Alme and Sjovall (4) on bile acid glucuronides from urine of man, which indicated the existence of only bile acid monoglucuronides. Due to the low sensitivity ofthe assay method available (22) for determination of UDP-glucuronosyltransferase activity toward the trihydroxylated bile acid cholic or toward glycine-and taurine-conjugated bile acids, only glycolithocholic acid was studied as substrate of UDP-glucuronosyltransferase(s) from human tissues. Since the rate of glycolithocholic acid glucuronidation with renal or duodenal microsomes was estimated to be <0.01 nmol/min per mg of protein, identification of glycolithocholic acid glucuronide as product of the enzymatic reaction was only performed for hepatic microsomes as enzyme source exhibiting a reaction rate of -0.05 nmol/min per mg of protein. As described above for the unconjugated bile acids, only one radioactive reaction product was obtained with labeled glycolithocholic acid as substrate of human hepatic microsomal UDP-glucuronosyltransferase. This reaction product exhibited the same Rf-value in thin-layer chromatography as reference glycolithocholic acid glucuronide enzymatically synthesized with rat liver microsomes, (22) and yielded glycolithocholic acid after incubation with ,B-glucuronidase if the /3-glucuronidase inhibitor saccharolactone was absent. UDP-glucuronosyltransferase activity toward the unconjugated bile acids, chenodeoxycholic acid, deoxycholic acid, ursodeoxycholic acid, and lithocholic acid could thus be found in microsomes of liver, kidney, and duodenum of man in addition to enzyme activity toward glycolithocholic acid that was detectable in microsomes of human liver.
In order to investigate whether or not UDP-glucuronosyltransferase activity toward bile acids is equally distributed throughout the whole human intestine, different segments of intestinal mucosa were assayed for UDP-glucuronosyltransferase activity toward chenodeoxycholic acid. As shown in Table I , a progressive decrease in microsomal UDP-glucuronosyltransferase activity toward chenodeoxycholic acid from the oral to the aboral end of intestinal mucosa was observed with the highest activity estimated in the duodenum and the lowest activity found in the colon.
In contrast to microsomes from human liver, kidney, or small intestinal mucosa, crude homogenate or microsomes that Bile acid UDP-glucuronosyltransferase activity in liver disease Since up to now no studies were available on UDP-glucuronosyltransferase activity toward bile acids in liver disease, a survey of glucuronidating activity toward chenodeoxycholic acid was carried out in liver biopsy specimens from patients with a variety of liver diseases (n = 75) or with normal liver histology (n = 23) (Fig. 1) . Patients with normal liver exhibited a mean value of UDP-glucuronosyltransferase activity toward chenodeoxycholic acid of 201±77.6 (SD) nmol/h per mg of DNA (0.063±0.024 (SD) nmol/min per mg of protein), which amounted to about twice the mean value observed in patients with liver cirrhosis (Fig. 1) . The mean value of bile acid UDPglucuronosyltransferase activity in patients with liver cirrhosis was not only significantly lower, compared to the mean value of enzyme activity estimated for the group with normal liver (P < 0.001), but differed also significantly from the mean values of bile acid UDP-glucuronosyltransferase activity from patients with fatty liver hepatitis (P < 0.02), fatty liver (P < 0.003), and fibrosis of the liver (P < 0.003). The mean value of bile acid UDP-glucuronosyltransferase activity from patients with granulomatous hepatitis differed only significantly from the mean value of enzyme activity observed for the group with normal liver (P < 0.03) (Fig. 1) . No significant differences were observed for the mean values of UDP-glucuronosyltransferase activity toward chenodeoxycholic acid between all other groups tested (Fig. 1) .
Since human hepatic UDP-glucuronosyltransferase activity toward chenodeoxycholic acid has been shown to be competitively inhibited by bilirubin, as described in previous reports (10, 1 1) , the values of UDP-glucuronosyltransferase activity to- (n * 9) (n . 23) Figure 1 . UDP-glucuronosyltransferase activity toward chenodeoxycholic acid in liver biopsy specimens from patients with normal liver and various liver disease. Enzyme activity and DNA were determined as described in Methods from 10% liver homogenates (wet weight/ volume) that was prepared with 0.25 M sucrose, which contained 5 mM Tris/HCl, pH 7.4. Horizontal lines represent means±SD. P values < 0.05 were considered significant when compared with the normal liver. n, number of liver biopsy specimens.
ward chenodeoxycholic acid obtained from human liver biopsy specimens shown in Fig. 1 were plotted against total serum bilirubin values. As shown in Fig. 2 , UDP-glucuronosyltransferase activity toward chenodeoxycholic acid exhibited an inverse correlation with the concentration of total serum bilirubin, i.e., low bile acid UDP-glucuronosyltransferase activity was observed in patients with high total serum bilirubin values. Whether or not the observed inverse correlation between total serum bilirubin and bile acid UDP-glucuronosyltransferase activity may be due to bilirubin acting as competitive inhibitor of chenodeoxycholic acid glucuronidation, as previously observed in in vitro studies (10, 1 1), or due to an unspecific inhibitory effect of bilirubin on UDP-glucuronosyltransferase because of its toxicity (34), can only be clarified when the purified UDP-glucuronosyltransferase becomes available.
Discussion
Previous studies have shown that glucuronidation is an important end step in bile acid metabolism, both in health (4, 35) as well as in liver disease (1) (2) (3) (4) 36) . However, up to now only the liver has been known as a site of bile acid glucuronidation in man (10, 1 1 ). The present study shows that in man, conjugation of bile acids with glucuronic acid does not only occur in the liver but also in the kidney and small intestinal mucosa. No enzyme activity could be detected in homogenates or microsomes of human adrenal.
The Vm.-values for the individual bile acids show that microsomal UDP-glucuronosyltransferase activity toward bile acids in liver is about twice that found in kidney and about twice to three times that observed in duodenal mucosa (Table II) activity toward chenodeoxycholic acid with total serum bilirubin concentrations. Enzyme activities were obtained from liver biopsy specimens of patients with and without liver disease (values of Fig. 1 ). Total serum bilirubin in these patients was determined as described in Methods.
relative glucuronidation rates with chenodeoxycholic acid in different segments of human intestinal mucosa indicate a decrease in the activity of UDP-glucuronosyltransferase toward bile acids when going from the oral end of the small intestine to the colon, where it is 30% of the duodenal level (Table I) . A similar decrease in rat intestinal enzyme activity from duodenum to ileum was observed for UDP-glucuronosyltransferase activity toward xenobiotics such as o-aminophenol and p-nitrophenol (14) , and for the mixed function monooxygenase system which catalyzes biotransformation of xenobiotics by oxidative reactions (37). Therefore, enzymes involved in the biotransformation of foreign or endogenous compounds either by glucuronidation or by oxidative reactions appear to be concentrated in the upper small intestine, which is also the region primarily exposed to bile acids of the enterohepatic circulating bile acid pool or to xenobiotics in the diet. With regard to bile acid metabolism, the upper small intestine, such as the jejunum, is mainly the site of passive absorption of bile acids, in contrast to the ileum, where bile acids are predominantly taken up by an active transport system (38, 39) . Since, according to the present study, the upper small intestine, such as the duodenum and the jejunum, is the site of high UDP-glucuronosyltransferase activity toward bile acids, passive absorption of these compounds may be associated with metabolism ofthese molecules, as already suggested by Rachmilewitz and Saunders (40) from studies on bile acid metabolism by rat intestinal mucosa. These authors observed that metabolism of bile acids during their absorption by rat intestinal segments is higher in the jejunum than in the ileum and colon, leading to the formation of polar bile acid metabolites that had not been further identified (40) . The apparent Km-values for the various bile acids as substrates indicate a similar affinity of the individual bile acids to the enzymes from liver, kidney, or small intestine (Table II) . Among the individual bile acids, differences in the affinities to the respective enzymes were observed independent of the source of enzyme. The monohydroxylated bile acid lithocholic acid exhibited an -4-15-fold higher affinity to the enzymes from liver, kidney, or small intestinal mucosa compared with the dihydroxylated bile acids chenodeoxycholic acid, deoxycholic acid, or ursodeoxycholic acid (Table II) . The dihydroxylated bile acids themselves showed differences in the affinities to the enzymes independent of the enzyme source, which suggested that the affinity of the bile acids to hepatic, renal, or small intestinal UDP-glucuronosyltransferase does not only depend on the number but also on the position and configuration of hydroxyl groups in the bile acid skeleton. Since within the dihydroxy bile acids, lowest affinity to the enzymes was observed for ursodeoxycholic acid, which has been shown to be significantly more hydrophilic than its 7a epimer chenodeoxycholic acid, and more hydrophilic than deoxycholic acid (41), these results suggest that the affinity of bile acids to hepatic, renal, and small intestinal UDP-glucuronosyltransferase appears to increase with increasing hydrophobicity of bile acids. Furthermore, conjugation of bile acids with amino acids appears to decrease the affinity of bile acids to UDP-glucuronosyltransferase, since in the presence of glycolithocholic acid a sixfold lower affinity to hepatic microsomal UDP-glucuronosyltransferase was observed, compared with unconjugated lithocholic acid (Table II) . Since, according to the present study in man, unconjugated bile acids appear to be substrates of higher affinity to hepatic and extrahepatic bile acid UDP-glucuronosyltransferase(s) (Table  II) Unconjugated primary, secondary, and tertiary bile acids were recently found in serum samples of healthy subjects (7, 42) , and were shown to increase to concentrations between two and three micromole per liter after breakfast (43) . The existence of unconjugated bile acids in serum of healthy subjects and the recent finding of more than 20 individual bile acid glucuronides in urine of healthy subjects, most of which were otherwise unconjugated (4), indicate that glucuronidation of unconjugated bile acids plays a physiological role in bile acid metabolism in health.
However, not only in health but also in patients with small bowel overgrowth or ileal resection, in patients with cholesterol cholelithiasis that was treated with chenodeoxycholic acid (44) or ursodeoxycholic acid (45) for gallstone dissolution, as well as in patients with hepatobiliary disease, glucuronidation of unconjugated bile acids may be of biological significance.
In patients with small bowel overgrowth or ileal resection, increased concentrations ofserum unconjugated bile acids have been found (42, 46) which may serve as substrates for hepatic and extrahepatic bile acid UDP-glucuronosyltransferase(s). This assumption is supported by the description of a patient with chronic malabsorption, who excreted glucuronides of otherwise unconjugated mainly 6a-hydroxylated bile acids in urine, which amounted to 20% of the total urinary bile acid excretion (47) .
In patients with cholesterol cholelithiasis, which was treated orally with chenodeoxycholic acid or ursodeoxycholic acid for gallstone dissolution, high concentrations ofthese unconjugated bile acids were found in serum immediately after oral application of these drugs (42, 48) . These serum unconjugated bile acids may serve as substrates for hepatic and extrahepatic bile acid UDP-glucuronosyltransferase(s), since glucuronides of chenodeoxycholic acid and ursodeoxycholic acid have been identified in serum (35) and urine of healthy subjects (4) . Since chenodeoxycholic acid and ursodeoxycholic acid are both metabolized to the toxic lithocholic acid (49, 50) , elevated concentrations of sulfated lithocholic acid as well as of nonsulfated lithocholic acid were found in serum and bile during treatment of patients with chenodeoxycholic acid or ursodeoxycholic acid for gallstone dissolution (50) . Due to the high affinity observed for lithocholic acid toward hepatic and extrahepatic UDP-glucuronosyltransferase(s) ( Table II) , glucuronidation of lithocholic acid may serve as a further detoxication mechanism in man in addition to the well-known sulfation (5, 51) , which is supported by the identification oflithocholic acid glucuronide in serum (35) and urine (4) of healthy subjects.
In patients with hepatobiliary disease, glucuronidation of unconjugated bile acids may be of biological significance, since analysis ofserum bile acid profiles in patients with liver cirrhosis indicated the existence of unconjugated bile acids in serum which amounted to 40% of total serum bile acids (52) . Furthermore, bile acid glucuronides, most of which were otherwise unconjugated, have been found in urine and bile of patients with liver disease (1) (2) (3) (4) .
UDP-glucuronosyltransferase activity toward chenodeoxycholic acid in liver biopsy specimens from patients with various liver diseases was found to be decreased in patients with cirrhosis or granulomatous hepatitis (Fig. 1) , compared with enzyme activity estimated in normal liver, whereas liver biopsy specimens from patients with fatty liver hepatitis, fatty liver, or fibrotic liver exhibited UDP-glucuronosyltransferase activity toward chenodeoxycholic acid that did not differ significantly from the enzyme activity estimated in normal liver. The reduced hepatic bile acid UDP-glucuronosyltransferase activity observed in patients with liver cirrhosis (Fig. 1) , as well as in patients with liver disease in connection with high total serum bilirubin values (Fig. 2) , is in agreement with levels of bile acid glucuronides that were recently estimated in urine and serum of healthy subjects (4, 35) and in patients with liver cirrhosis or patients with other intrahepatic or extrahepatic cholestasis (2-4, 35, 36) . These levels of bile acid glucuronides were recently determined using highly specific analysis such as lipophilic anion exchange (2-4) or mass fragmentography (35, 36).
Takikawa et al. (36) recently found diminished serum bile acid glucuronides in patients with compensated liver cirrhosis (2.7% of total serum bile acids), in patients with jaundiced liver cirrhosis (0.9% of total serum bile acids), and in patients with obstructive jaundice (5.1% of total serum bile acids), whereas in healthy subjects, 8 .6% of the total serum bile acids were glucuronidated (36). Alme and Sjovall (4) showed that in healthy subjects bile acid glucuronides represented 12-36% of the total bile acids excreted in urine, whereas in mild cholestasis, 8.4% ofthe total urinary bile acids were bile acid glucuronides. Levels of urinary bile acid glucuronides in patients with liver cirrhosis were determined recently to be 6.8 (2) or 2.2% (3) of total urinary bile acids, and were therefore lower than those estimated for healthy subjects (12-36%) (4) .
According to the results of the present study, the reduced relative amounts of serum (36) or urinary bile acid glucuronides (2, 3) that were observed in patients with liver cirrhosis (2, 3, 36) or in patients with other intrahepatic (4) or extrahepatic cholestasis (36), compared with the relative amounts ofbile acid glucuronides in serum (35, 36) or urine (4) of healthy subjects, may be explained by a decrease in hepatic bile acid UDP-glucuronosyltransferase activity in liver cirrhosis as well as in liver disease in connection with high serum bilirubin values. The decreased hepatic UDP-glucuronosyltransferase activity toward chenodeoxycholic acid that was observed in patients with liver cirrhosis or granulomatous hepatitis (Fig. 1) may be explained by the reduced amounts of hepatocytes per milligram of DNA, by hepatocellular dysfunction and/or by an inhibitory effect of bilirubin on bile acid UDP-glucuronosyltransferase activity (10, 1 1), since low enzyme activities in liver biopsy specimens of patients with cirrhosis or with granulomatous hepatitis were found when serum bilirubin values were in the normal or elevated range (Figs. 1 and 2) .
The presented results are the first report which indicates that not only the liver but also the intestinal mucosa and the kidney are able to glucuronidate bile acids in man. However, the relative contribution of hepatic and extrahepatic sites to the formation of bile acid glucuronides in man still has to be determined.
